Organic Letters
Letter
Sudhakara Rao, J.; Calvet, J. P. U.S. Patent 20090197911, 2009.
(d) Tash, J. S.; Chakrasali, R.; Jakkaraj, S. R.; Hughes, J.; Smith, S. K.;
Hornbaker, K.; Heckert, L. L.; Ozturk, S. B.; Hadden, M. K.; Kinzy, T.
G.; Blagg, B. S. J.; Georg, G. I. Biol. Reprod. 2008, 78, 1139.
(e) Catanese, B.; Lagana, A.; Marino, A.; Picollo, R.; Rotatori, M.
Pharmacol. Res. Commun. 1986, 18, 385. (f) Lang, D. H.; Rettie, A. E.
Br. J. Clin. Pharmacol. 2000, 50, 311. (g) Stormer, E.; Roots, I.;
Brockmoller, J. Br. J. Clin. Pharmacol. 2000, 50, 553.
Scheme 6. Mechanistic Hypothesis for the N−N Bond
Formation
(3) For references on indazole-type alkaloids, see: (a) Yuan, T.;
Nahar, P.; Sharma, M.; Liu, K.; Slitt, A.; Aisa, H. A.; Seeram, N. P. J.
Nat. Prod. 2014, 77, 2316. (b) Liu, Y.-M.; Jiang, Y.-H.; Liu, Q.-H.;
Chen, B.-Q. Phytochem. Lett. 2013, 6, 556. (c) Ali, Z.; Ferreira, D.;
Carvalho, P.; Avery, M. A.; Khan, I. A. J. Nat. Prod. 2008, 71, 1111.
(4) (a) Caron, S.; Vazquez, E. Synthesis 1999, 1999, 588. (b) Lukin,
K.; Hsu, M. C.; Fernando, D.; Leanna, M. R. J. Org. Chem. 2006, 71,
8166. (c) Pabba, C.; Wang, H.-J.; Mulligan, S. R.; Chen, Z.-J.; Stark, T.
M.; Gregg, B. T. Tetrahedron Lett. 2007, 63, 2695.
(5) (a) Yu, D.-G.; Suri, M.; Glorius, F. J. Am. Chem. Soc. 2013, 135,
8802. (b) Lian, Y.; Bergman, R. G.; Lavis, L. D.; Ellman, J. A. J. Am.
Chem. Soc. 2013, 135, 7122. (c) Hu, J.; Cheng, Y.; Yang, Y.; Rao, Y.
Chem. Commun. 2011, 47, 10133.
(6) For recent reviews on copper-catalyzed synthesis of heterocycles,
see: (a) Guo, X.-X.; Gu, D.-W.; Wu, Z.; Zhang, W. Chem. Rev. 2015,
115, 1622. (b) Chiba, S. Bull. Chem. Soc. Jpn. 2013, 86, 1400.
(c) Subramanian, P.; Rudolf, G. C.; Kaliappan, K. P. Chem. - Asian J.
2016, 11, 168.
(7) For recent reviews on using O2 as the terminal oxidant, see:
(a) Wendlandt, A. E.; Suess, A. M.; Stahl, S. S. Angew. Chem., Int. Ed.
2011, 50, 11062. (b) Campbell, A. N.; Stahl, S. S. Acc. Chem. Res.
2012, 45, 851. (c) Allen, S. E.; Walvoord, R. R.; Padilla-Salinas, R.;
Kozlowski, M. C. Chem. Rev. 2013, 113, 6234.
(8) For recent examples of copper-catalyzed N−N bond formation,
see: (a) Ueda, S.; Nagasawa, H. J. Am. Chem. Soc. 2009, 131, 15080.
(b) He, H.-F.; Wang, Z.-J.; Bao, W. Adv. Synth. Catal. 2010, 352, 2905.
(c) Bartels, B.; Bolas, C. G.; Cueni, P.; Fantasia, S.; Gaeng, N.; Trita, S.
J. Org. Chem. 2015, 80, 1249. (d) Peng, J.; Xie, Z.; Chen, M.; Wang, J.;
Zhu, Q. Org. Lett. 2014, 16, 4702. (e) Wu, Q.; Zhang, Y.; Cui, S. Org.
Lett. 2014, 16, 1350. (f) Sudheendran, K.; Schmidt, D.; Frey, W.;
Conrad, J.; Beifuss, U. Tetrahedron 2014, 70, 1635. (g) Hirayama, T.;
Ueda, S.; Okada, T.; Tsurue, N.; Okuda, K.; Nagasawa, H. Chem. - Eur.
J. 2014, 20, 4156. (h) Xu, H.; Ma, S.; Xu, Y.; Bian, L.; Ding, T.; Fang,
X.; Zhang, W.; Ren, Y. J. Org. Chem. 2015, 80, 1789.
Cu(OAc)2-catalyzed N−N bond formation using oxygen as the
terminal oxidant. This protocol takes advantage of the readily
accessible ketimine precursors prepared from o-aminobenzoni-
triles and organometallic reagents. The simplicity and high
efficiency of this protocol renders it attractive when compared
to the others reported in the literature. Importantly, both
nitrogen atoms in the starting material were conserved. The
method demonstrated here allows easy access to structurally
diverse 1H-indazoles and could serve as a versatile tool for the
modular synthesis of 1H-indazole containing medicinal agents.
We hope this work will prompt others to explore application of
the N−N bond formation methodology using o-amino
ketimines in the arena of heterocycle syntheses.
ASSOCIATED CONTENT
* Supporting Information
■
S
The Supporting Information is available free of charge on the
Experimental details, characterization data, and NMR
(9) (a) Wray, B. C.; Stambuli, J. P. Org. Lett. 2010, 12, 4576.
(b) Counceller, C. M.; Eichman, C. C.; Wray, B. C.; Stambuli, J. P.
Org. Lett. 2008, 10, 1021.
(10) Addition of organometallics to o-aminoaryl nitrile followed by
hydrolysis of the imine species serves as an effective protocol to
prepare o-aminoacetophenones. For examples, see: (a) the Supporting
Information in ref 6. (b) Cook, J. M.; Zhang, W.; Liu, R. Heterocycles
1993, 36, 2229. (c) Huang, J.; Mao, T.; Zhu, Q. Eur. J. Org. Chem.
2014, 2014, 2878. (d) Ellis, D.; Kuhen, K. L.; Anaclerio, B.; Wu, B.;
Wolff, K.; Yin, H.; Bursulaya, B.; Caldwell, J.; Karanewsky, D.; He, Y.
Bioorg. Med. Chem. Lett. 2006, 16, 4246.
(11) Only a few o-aminoaryl imine species have been isolated and
characterized, and their synthetic utilization remains scarce. For
examples, see: (a) Ozeryanskii, V. A.; Pozharskii, A. F.; Antonov, A. S.;
Filarowski, A. Org. Biomol. Chem. 2014, 12, 2360. (b) Adachi, M.;
Sasakura, K.; Sugasawa, T. Chem. Pharm. Bull. 1985, 33, 1826.
(c) Dubrovskiy, A.; Larock, R. C. J. Org. Chem. 2012, 77, 11232.
(12) Preparation and isolation of ketamine 7 is straightforward, and
the crude intermediate was directly used in the N−N bond formation
without further purification: For details, see the Supporting
AUTHOR INFORMATION
Corresponding Author
■
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We acknowledge Mrs. Yiping Zhang and Mrs. Jingjing Shi at
Porton (Shanghai) R&D Center for analytical support. We also
acknowledge Mr. Peter J. Yao of Janssen R&D at Cilag AG for
helpful discussions during the preparation of this manuscript.
REFERENCES
■
(1) For a recent review on the synthesis and biological activities of
indazoles, see: (a) Gaikwad, D. D.; Chapolikar, A. D.; Devkate, C. G.;
Warad, K. D.; Tayade, A. P.; Pawar, R. P.; Domb, A. J. Eur. J. Med.
Chem. 2015, 90, 707. (b) Stadlbauer, W. Sci. Synth. 2002, 12, 227.
(2) For references on selected indazole drugs, see: (a) Chaturvedula,
A.; Joshi, D. P.; Anderson, C.; Morris, R.; Sembrowich, W. L.; Banga,
A. K. Pharm. Res. 2005, 22, 1313. (b) Bermudez, J.; Fake, C. S.; Joiner,
G. F.; Joiner, K. A.; King, F. D.; Miner, W. D.; Sanger, G. J. J. Med.
Chem. 1990, 33, 1924. (c) George, I. G.; Tash, J. S.; Chakrasali, R.;
(13) For biological activities and preparation of N-arylindazoles, see:
(a) Yates, C. M.; Brown, P. J.; Stewart, E. L.; Patten, C.; Austin, R. J.
H.; Holt, J. A.; Maglich, J. M.; Angell, D. C.; Sasse, R. Z.; Taylor, S. J.;
Uings, I. J.; Trump, R. P. J. Med. Chem. 2010, 53, 4531. (b) Salovich, J.
M.; Lindsley, C. W.; Hopkins, C. R. Tetrahedron Lett. 2010, 51, 3796.
D
Org. Lett. XXXX, XXX, XXX−XXX